Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Zhao, Kai ^a,b   Chen, Gang ^a   Shi, Xing ming ^b   Gao, Ting ting ^a   Li, Wei ^a,b   Zhao, Yan ^b   Zhang, Feng qiang ^a   Wu, Jin ^a   Cui, Xianlan ^c   Wang, Yun Feng ^b  

^a HEILONGJIANG UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN NANOPARTICLE; INACTIVATED VACCINE; LIVE VACCINE; NANOPARTICLE; NEWCASTLE DISEASE VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EMBRYO; FATALITY; IMMUNIZATION; IMMUNOMODULATION; INFECTION PREVENTION; NANOENCAPSULATION; NEWCASTLE DISEASE; NONHUMAN; VACCINE PRODUCTION; VIRUS RELEASE; VIRUS STRAIN; VIRUS VIRULENCE; WESTERN BLOTTING; ZETA POTENTIAL;

ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; CHITOSAN; DRUG COMPOUNDING; NANOPARTICLES; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; RANDOM ALLOCATION; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 84871684257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053314     Document Type: Article

References (58)

1. Liu HL, Wang ZL, Wu YG, Wu Y, Sun CY, et al. (2008) Molecular characterization and phylogenetic analysis of new Newcastle disease virus isolates from the mainland of China. Res Vet Sci 85: 612-616.
2. Arifin MA, Mel M, Karim MIA, Ideris A, (2010) Production of Newcastle disease virus by Vero cells grown on Cytodex 1 microcarriers in a 2-liter stirred tank bioreactor. J Biomed Biotechnol 2010: 1-7.
3. Chimeno Zoth S, Gómez E, Carrillo E, Berinstein A, (2008) Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. Braz J Med and Biol Res 41: 318-323.
4. Henderson A, Propst K, Kedlc R, Dow S, (2011) Mucosal immunization with liposome-nucleic acid adjuvant generates effective humoral and cellular immunity. Vaccine 29: 5304-5312.
5. Fan H, Lin Q, Morrissey GR, Khavari PA, (1999) Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 17(9): 870-872.
6. Fan M, Hu QL, Shen K, (2009) Preparation and structure of chitosan soluble in wide pH range. Carbohyd Polym 78: 66-71.
7. Moura MR, Aouada FA, Mattoso LH, (2008) Preparation of chitosan nanoparticles using methacrylic acid. J Colloid Interface Sci 321(2): 477-483.
8. Aspden TJ, Mason JD, Jones NS, Lowe J, Skaugrud O, et al. (1997) Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 86(4): 509-513.
9. Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S, Prakash S, (2011) A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis. Int J Nanomedicine 6: 485-494.
10. Zhao K, Shi XM, Zhao Y, Wei HX, Sun QS, et al. (2011) Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine 29(47): 8549-8556.
11. Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, et al. (2011) Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 6: 765-774.
12. Newman KD, Elamanchili P, Kwon GS, Samuel J, (2002) Uptake of poly (D, L-lactic-co-glycolic acid) microspheres by antigen presenting cells in vivo. J Biomed Mater Res 60(3): 480-486.
13. Kavanagh OV, Earley B, Murray M, Foster CJ, Adair BM, (2003) Antigen specific IgA and IgG responses in calves inoculated intranasal with albumin encapsulated in poly D, L-lactide-co-glycolide microspheres. Vaccine 21: 4472-4480.
14. Ruberti M, De Melo LK, Dos Santos SA, Brandao IT, Soares EG, et al. (2004) Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. J Drug Target 12(4): 195-203.
15. Jin HL, Li YJ, Ma ZH, Zhang FC, Xie QG, et al. (2004) Effect of chemical adjuvants on DNA vaccination. Vaccine 22: 2925-2935.
16. Kasturi SP, Sachaphibulkij K, Roy K, (2005) Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 5(267): 6375-6385.
17. Chen YJ, Xu XY, Zhou JP, (2007) Research advance in PLGA microspheres. J Chin Pharm Uni 38(2): 186-189.
18. Rouse J, Mohamed F, van der Walle CF, (2007) Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int J Pharm 2(28): 112-120.
19. Mok H, Park TG, (2008) Direct plasmid DNA encapsulation within PLGA microspheres by single oil-in-water emulsion method. Eur J Pharm Biopharm 68(1): 105-111.
20. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE, (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62: 59-82.
21. Xu YM, Du YM, Huang RH, Gao LP, (2003) Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 24: 5015-5022.
22. Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, et al. (2007) N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model. Vaccine 25: 144-153.
23. Coria MF, (1972) Stabilizing effect of magnesium sulfate on avian infectious bronchitis virus propagated in chicken embryo kidney cells. Appl Microbiol 23: 281-284.
24. Sonia TA, Sharma Chandra P, (2011) In vitro evaluation of N-(2-hydroxy) propyl-3-trimethyl ammonium chitosan for oral insulin delivery. Carbohydrate Polymers. 84: 103-109.
25. Liu SW, Chen HY, Cao DJ, Lu JL, (1998) Effect on chicken lymphocytes by Newcastle disease virus. Chin J Animal Poult Infect Dis 20(3): 140-142.
26. Tseng LP, Chiou CJ, Deng MC, Lin MH, Pan RN, et al. (2009) Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity. J Biomed Mater Res Part B: Appl Biomater 91B (2): 621-625.
27. Partidos CD, (2000) Intranasal vaccines: Forthcoming challenges. Pharm Sci Technolo Today 3: 273-281.
28. Davis SS, (2001) Nasal vaccines. Adv Drug Deliv Rev 51: 21-42.
29. Ugwoke MI, Agu RU, Verbeke N, Kinget R, (2005) Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Deliv Rev 57: 1640-1665.
30. Türker S, Onur E, Ozer Y, (2004) Nasal route and drug delivery systems. Pharm World Sci 26(3): 137-142.
31. Kang ML, Kang SG, Jiang HL, Guo DD, Lee DY, et al. (2008) Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in pigs. J Microbiol Biotechnol (6): 1179-1185.
32. Gavini E, Hegge AB, Rassu G, Sanna V, Testa C, et al. (2005) Nasal administration of carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int J Pharm 307: 9-15.
33. Varshosaz J, Sadrai H, Alinagari R, (2004) Nasal delivery of insulin using chitosan microspheres. J Microencapsul 21: 761-774.
34. Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, et al. (2004) Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies. J Control Release 98: 269-279.
35. Senel S, Kremer MJ, Kas S, Wertz PW, Hincal AA, et al. (2000) Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 21: 2067-2071.
36. Yu W, Xie H, (2012) A Review on nanofluids: Preparation, stability mechanisms, and applications. J Nanomaterials. 2012 (2012): 1-17.
37. Marino OC, Hanson RP, (1987) Cellular and humoral response of in ovo-bursectomized chickens to experimental challenge with velogenic disease virus. Avian Dis 31: 293-301.
38. Merz DC, Scheid A, Choppin P, (1981) Immunological studies of the functions of paramyxovirus glycoprotein. Virology 28: 208-221.
39. Reynolds DL, Maraqa AD, (2000) Protective immunity against Newcastle Disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis 44: 138-144.
40. Reynolds DL, Maraqa AD, (2000) Protective Immunity against Newcastle Disease: The role of cell-mediated immunity. Avian Dis 44(1): 145-154.
41. Alexander DJ, Senne DA (2008) Newcastle disease, other avian paramyxoviruses, and pneumovirus infections. In: Saif YM, Fadly AM, Glisson JR, McDougald LR, Nolan LK, et al., editors. Diseases of Poultry. 12th ed. Ames, IA: Blackwell Publishing Professional. 75-115.
42. Van Boven M, Bouma A, Fabri THF, Katsma E, Hartog L, et al. (2008) Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol 37(1): 1-5.
43. Kapczynski DR, King DJ, (2005) Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 23: 3424-3433.
44. Jayawardane GW, Spradbrow PB, (1995) Mucosal immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Vet Microbiol 46(1-3): 69-77.
45. Spradbrow PB (1992) A review of the use of food carriers for the delivery or oral Newcastle disease vaccine. In: Spradbrow PB, editor. Newcastle Disease in Village Chickens. Proceedings of an international workshop held in Kuala Lumpur, Malaysia. Canberra: Australian Centre for International Agricultural Research. 18-20.
46. Ghumman JS, Bankowski E, (1976) In vitro DNA synthesis in lymphocytes from turkeys vaccinated with La Sota, TC and inactivated Newcastle disease vaccines. Avian Dis 20: 18-31.
47. Russell PH, Dwivedi PN, Davison TF, (1997) The effect of cyclosporin A and cyclophosphamide on the populations of B and T cells and virus in the Harderian gland of chickens vaccinated with the Hitchner B1 strain of Newcastle disease virus. Vet Immunol Immunopathol 60: 171-185.
48. Takada A, Kida H, (1996) Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet Microbiol 50: 17-25.
49. Russell PH, Ezeifeka GO, (1995) The Hitchner B1 strain of Newcastle disease virus induces high levels of IgA, IgG and IgM in newly hatched chicks. Vaccine 13(1): 61-66.
50. Ewert DL, Eidson CS, (1977) Effect of bursectomy and depletion of immunoglobulin A on antibody production and resistance to respiratory challenge after local or systemic vaccination of chickens with Newcastle Disease Virus. Infect Immun 18: 146-150.
51. Boyoglu S, Vig K, Pillai S, Rangari V, Dennis VA, et al. (2009) Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus. Nanomedicine 5(4): 463-472.
52. Xu J, Dai W, Wang Z, Chen B, Li Z, et al. (2011) Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen A protects mice against nasopharyngeal colonization by Streptococcus pneumonia. Clin Vaccine Immunol 18(1): 75-81.
53. Zhao F, Wang S, Zhang X, Gu W, Yu J, et al. (2012) Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2. Can J Microbiol 58: 117-123.
54. World Organisation for Animal Health (OIE). Newcastle Disease (Version adopted by the World Assembly of Delegates of the OIE in May 2012). In: OIE Terrestrial Manual 2012. Paris: OIE; 2012. Available: http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.03.14_NEWCASTLE_DIS.pdf. Accessed 2012 Oct 5.
55. Bwala DG, Fasina FO, Van Wyk A, Duncan NM, (2011) Effects of vaccination with Lentogenic vaccine and challenge with virulent Newcastle disease virus (NDV) on egg production in commercial and SPF chickens. Int J Poult Sci 10 (2): 98-105.
56. Echeonwu GON, Iroegbu CU, Echeonwu BC, Ngene A, Nwosuh CI, et al. (2008) Immune response and protection of free range chickens vaccinated orally with feeding of Newcastle disease vaccine-coated cassava granules. Afr J Microbiol Res 2: 120-125.
57. Jeon WJ, Lee EK, Lee YJ, Jeong OM, Kim YJ, et al. (2008) Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain. J Vet Sci 9: 295-300.
58. Yan Z, Du Y, Zhao Q, Fan R, Guo W, et al. (2011) Mucosal immune responses against live Newcastle disease vaccine in immunosuppressed chickens. Pak Vet J 31: 280-286.